See also this year's filing and all EDGAR filings for this company.
PDF Report 0001005201_2020_Assertio_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 1.3723216001132537, 'aggregate_val': 469212000, 'exp_sum': 197786000, 'exp_to_value': {'LiabilitiesCurrent': 184553000, 'LiabilitiesNoncurrent': 13233000, 'remainder_Liabilities': 0}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001005201')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001005201, Assertio Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 103,951,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 400,535,000 |
| 2 | PropertyPlantAndEquipmentNet | 3,497,000 |
| 3 | remainder_Assets | 19,187,000 |
| 4 | LiabilitiesCurrent | 184,553,000 |
| 5 | LiabilitiesNoncurrent | 13,233,000 |
| 6 | remainder_Liabilities | 271,426,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 108,866,000 |
| 9 | ResearchAndDevelopmentExpense | 10,106,000 |
| 10 | remainder_Expenses | 299,660,000 |
| 11 | remainder_Revenues | 229,504,000 |
| 12 | remainder_NetIncome | -28,056,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 527,170,000 |
| 1 | Liabilities | 469,212,000 |
| 2 | Expenses | 418,632,000 |
| 3 | Revenues | 229,504,000 |
| 4 | StockholdersEquity | 57,958,000 |
| 5 | NetIncome | -217,184,000 |
| 6 | ComprehensiveNetIncome | -217,184,000 |
| 7 | BaseVar | 836,287,000 |
| 8 | EconomicCapitalRatio | -0.236 |
Edgar->Model Mapping
Feature Distribution
Change over Time
